Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

Overview of attention for article published in Cancer Medicine, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 3 news stories from 1 outlets.

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States

Doc Wire News, 09 May 2022

This article was originally published here Cancer Med. 2022 May 8. doi: 10.1002/cam4.4797.

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States

Doc Wire News, 09 May 2022

This article was originally published here Cancer Med. 2022 May 8. doi: 10.1002/cam4.4797.

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States

Doc Wire News, 09 May 2022

This article was originally published here Cancer Med. 2022 May 8. doi: 10.1002/cam4.4797.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.